Abstract: A battery pack for use with a power tool having an electric connector. The battery pack including a housing containing one or more battery cells, a first terminal in electrical communication with the battery cells, the first terminal including a pair of spaced apart terminal walls forming a gap therebetween and a coil spring at least partially positioned within the gap. Where the coil spring is configured to selectively engage and form an electrical connection with the electric connector of the power tool when the electric connector is at least partially positioned within the gap.

Abstract: The present invention relates to compounds of the Formula (I), or a pharmaceutically acceptable salt, pharmaceutical preparation, or pharmaceutical composition thereof, and their use for the treatment of pain, inflammatory disease, neuropathy, dermatological disorders, pulmonary conditions, and cough, as well as inhibiting the Transient Receptor Potential A1 ion channel (TRPA1).

Abstract: The present invention relates to compounds of the Formula (I), or a pharmaceutically acceptable salt, pharmaceutical preparation, or pharmaceutical composition thereof, and their use for the treatment of pain, inflammatory disease, neuropathy, dermatological disorders, pulmonary conditions, and cough, as well as inhibiting the Transient Receptor Potential A1 ion channel (TRPA1).

Abstract: The present invention relates to compounds of the Formula (I), or a pharmaceutically acceptable salt, pharmaceutical preparation, or pharmaceutical composition thereof, and their use for the treatment of pain, inflammatory disease, neuropathy, dermatological disorders, pulmonary conditions, and cough, as well as inhibiting the Transient Receptor Potential A1 ion channel (TRPA1).

Abstract: This disclosure describes novel compounds and pharmaceutical compositions for inhibiting the TRPA1 ion channel and/or medical conditions related to TRPA1, such as pain and respiratory conditions.

Abstract: This disclosure describes novel compounds and pharmaceutical compositions for inhibiting the TRPA1 ion channel and/or medical conditions related to TRPA1, such as pain and respiratory conditions.

Abstract: A capacity control system for a variable capacity refrigerant compressor includes an internal bleed passage coupling a crankcase chamber of the compressor to a suction port, an electrically-operated two-port control valve that selectively opens and closes a passage between the crankcase chamber and a discharge chamber, and pressure sensors for measuring the compressor discharge pressure and suction pressure. A plunger of the control valve is disposed within the passage coupling the crankcase chamber and the discharge chamber, and a solenoid armature linearly positions the plunger within the passage to open and close the passage. The plunger has an axial bore that forms a continuous passage between the discharge chamber and a cavity in which the discharge pressure sensor is retained so that the sensor is continuously exposed to the discharge pressure regardless of the plunger position.

Abstract: A capacity control system for a variable capacity refrigerant compressor includes an internal bleed passage coupling a crankcase chamber of the compressor to a suction port, an electrically-operated two-port control valve that selectively opens and closes a passage between the crankcase chamber and a discharge chamber, and at least one pressure sensor within the control valve that is continuously coupled to the discharge chamber for measuring the compressor discharge pressure. A plunger of the control valve is disposed within the passage coupling the crankcase chamber and the discharge chamber, and a solenoid armature linearly positions the plunger within the passage to open and close the passage. The plunger has an axial bore that forms a continuous passage between the discharge chamber and a cavity in which the pressure sensor is retained so that the sensor is continuously exposed to the discharge pressure regardless of the plunger position.